ANDA 75450, held by Heritage Pharmaceuticals. Methylphenidate Hydrochloride.
As of Nov 21, 2026, ANDA 75450 (Methylphenidate Hydrochloride), held by Heritage Pharmaceuticals, was first approved by FDA on Dec 21, 2001, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 2001 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylphenidate Hydrochloride20MG · tablet, extended release;oral | Methylphenidate Hydrochloride | Discontinued |
| Sep 23, 2025 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jun 25, 2021 | Supplement 8Labeling · Standard review | Approved | None posted |
| Dec 21, 2001 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters